Stock Events

Stock Events

Kyowa Kirin. 

$15.38
20
-$0.25-1.6% Friday 18:49

Statistics

Day High
16.16
Day Low
16.16
52W High
18.66
52W Low
14.29
Volume
100
Avg. Volume
293
Mkt Cap
8.08B
P/E Ratio
16.91
Dividend Yield
2.62%
Dividend
0.4

Upcoming

Dividends

2.62%Dividend Yield
Apr 26
$0.20
Sep 25
$0.20
Apr 25
$0.19
Sep 24
$0.20
Apr 24
$0.19
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
2.6%

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.08
0.19
0.31
0.42
Expected EPS
0.23629525777
Actual EPS
N/A

Financials

13.3%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
3.27BRevenue
435.06MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KYKOY. It's not an investment recommendation.
Japan Tobacco
5
2914.TSE
Takeda Pharmaceutical
4
4502.TSE
Johnson & Johnson
3
JNJ
AT&T
3
T

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Takeda Pharmaceutical
TAK
Mkt Cap57.58B
Takeda Pharmaceutical Company Limited is a major competitor in the pharmaceutical industry, competing in similar therapeutic areas as Kyowa Kirin, such as oncology and gastroenterology.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC operates in various pharmaceutical sectors, including those that overlap with Kyowa Kirin's focus areas like oncology, making it a direct competitor.
Novartis
NVS
Mkt Cap292.35B
Novartis AG competes with Kyowa Kirin in multiple areas, including research and development in innovative medicines, particularly in oncology and rare diseases.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a global pharmaceutical company that competes with Kyowa Kirin in the development and marketing of medications in various therapeutic areas, including oncology.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. is involved in the discovery, development, and marketing of pharmaceuticals in areas like oncology, directly competing with Kyowa Kirin's product offerings.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes with Kyowa Kirin in the pharmaceutical and biotechnology sectors, especially in oncology and neurology, areas of focus for Kyowa Kirin.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline plc competes with Kyowa Kirin in pharmaceuticals and vaccines, with overlapping interests in areas such as immunology.
Sanofi
SNY
Mkt Cap107.39B
Sanofi competes with Kyowa Kirin in the global healthcare market, particularly in areas like immunology and oncology.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb Company is a competitor in the pharmaceutical industry, focusing on areas like oncology, which overlaps with Kyowa Kirin's interests.
AMGEN
AMGN
Mkt Cap233.78B
Amgen Inc. competes with Kyowa Kirin in the biopharmaceutical sector, particularly in the development of treatments for serious illnesses including oncology and bone disorders.

About

KYOWA HAKKO KOGY UNSP/ADR
Show more...
CEO
Abdul Hafeez Mullick
Country
Japan
ISIN
US50156R1077

Listings

TSE
JP
4151.TSE
STU
DE
KY4.STU
MU
DE
KY4.MU
OTC Link
US
KYKOF

0 Comments

Share your thoughts

FAQ

What is Kyowa Kirin. stock price today?▼
The current price of KYKOY is $15.38 USD — it has decreased by -1.6% in the past 24 hours. Watch Kyowa Kirin. stock price performance more closely on the chart.
What is Kyowa Kirin. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Kyowa Kirin. stocks are traded under the ticker KYKOY.
Is Kyowa Kirin. stock price growing?▼
KYKOY stock has fallen by -7.23% compared to the previous week, the month change is a -6.82% fall, over the last year Kyowa Kirin. has showed a +3.19% increase.
What is Kyowa Kirin. market cap?▼
Today Kyowa Kirin. has the market capitalization of 8.08B
When is the next Kyowa Kirin. earnings date?▼
Kyowa Kirin. is going to release the next earnings report on October 29, 2026.
What were Kyowa Kirin. earnings last quarter?▼
KYKOY earnings for the last quarter are 0.22 USD per share, whereas the estimation was 0.21 USD resulting in a +4.27% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kyowa Kirin. revenue for the last year?▼
Kyowa Kirin. revenue for the last year amounts to 3.27B USD.
What is Kyowa Kirin. net income for the last year?▼
KYKOY net income for the last year is 435.06M USD.
Does Kyowa Kirin. pay dividends?▼
Yes, KYKOY dividends are paid semi-annual. The last dividend per share was 0.2 USD. As of today, Dividend Yield (FWD)% is 2.62%.
In which sector is Kyowa Kirin. located?▼
Kyowa Kirin. operates in the Health & Wellness sector.
When did Kyowa Kirin. complete a stock split?▼
Kyowa Kirin. has not had any recent stock splits.
Where is Kyowa Kirin. headquartered?▼
Kyowa Kirin. is headquartered in Tokyo, Japan.